Evidence map›Paper›PMID 39546309›Full record

ArticleJAMA network open2024

Perspectives on Telemedicine Visits Reported by Patients With Cancer.

Sahil D Doshi, Yasin Khadem Charvadeh, Kenneth Seier, Erin M Bange, Bobby Daly, Allison Lipitz-Snyderman, Fernanda C G Polubriaginof, Michael Buckley, Gilad Kuperman, Peter D Stetson and 3 more

Abstract read
In one paragraph

Article in JAMA network open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Psychological distress in patients with hematological malignancies during the 2023-2025 war in Israel: a national survey and comparison with the COVID-19 pandemic.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  3. Article
  4. Canadian oncology nursing journal = Revue canadienne de nursing oncologique · 2026
    Article
  5. Trends in Telemedicine at a Cancer Center: Analyzing Sustained Use.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sahil D DoshiMemorial Sloan Kettering Cancer Center, New York, New York.
Yasin Khadem CharvadehMemorial Sloan Kettering Cancer Center, New York, New York.
Kenneth SeierMemorial Sloan Kettering Cancer Center, New York, New York.
Erin M BangeMemorial Sloan Kettering Cancer Center, New York, New York.
Bobby DalyMemorial Sloan Kettering Cancer Center, New York, New York.
Allison Lipitz-SnydermanMemorial Sloan Kettering Cancer Center, New York, New York.
Fernanda C G PolubriaginofMemorial Sloan Kettering Cancer Center, New York, New York.
Michael BuckleyMemorial Sloan Kettering Cancer Center, New York, New York.
Gilad KupermanMemorial Sloan Kettering Cancer Center, New York, New York.
Peter D StetsonMemorial Sloan Kettering Cancer Center, New York, New York.
Deb SchragMemorial Sloan Kettering Cancer Center, New York, New York.
Michael J MorrisMemorial Sloan Kettering Cancer Center, New York, New York.
Katherine S PanageasMemorial Sloan Kettering Cancer Center, New York, New York.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Research & Methods CoreP50CA271357 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI MICHAEL J MORRIS, KATHERINE S PANAGEAS · 2022 to 2026
$7.7M
Oncology-focused Postdoctoral Training in Care Delivery and Symptom Science (OPTICS)T32CA275764 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI JONINE L. BERNSTEIN, JUN J MAO · 2023 to 2026
$1.8M
NCI NIH HHS P30 CA008748NCI NIH HHS P50 CA271357NCI NIH HHS T32 CA275764
6 · The paper itself

Abstract

Importance: The COVID-19 pandemic catalyzed rapid adoption of telemedicine visits for cancer care delivery. However, patients' experiences with telemedicine remain poorly understood. Objective: To understand patients' satisfaction with telemedicine visits at a comprehensive cancer center. Design, Setting, and Participants: This survey study included patients with cancer at a US cancer center between 2020 and 2023. Eligible patients completed surveys in English conducted after their first telemedicine appointment via an online patient portal. Data were analyzed between January and June 2024. Exposures: Patient surveys about telemedicine experiences, with a specific comparison with an in-person visit. Structured items elicited satisfaction with the specific visit, preferences for future use of telemedicine, and technical ease of use; unstructured free-text responses were also elicited. Main Outcomes and Measures: Proportion of patients who indicated that telemedicine visits were superior or preferred to in-person visits. Secondary outcomes included multivariable analysis of barriers to telemedicine use and variations in patient experiences by demographic characteristics over the observation period, and free-text analysis of unstructured responses describing the telemedicine experience using the BERTopic algorithm and a language model. Results: A total of 27 435 telemedicine users completed surveys from May 2020 to October 2023 (median [IQR] age, 65 [55-72] years; 15 072 female [54.9%]; 1771 Asian [6.7%], 1339 Black [5.1%], 22 742 White [85.9%]). Overall, 18 025 of 24 418 patients (73.8%) rated their first telemedicine visit as good as or better than an in-person visit, and 4606 (18.9%) rated it superior to an in-person visit. The proportion of patients rating a telemedicine visit superior to an in-person visit evolved from 17% in 2020 to 20% in 2023. Structured questions revealed a positive view of telemedicine, while free-text analyses highlighted issues with technology. Conclusions and Relevance: In this survey study of perspectives on telemedicine visits, a large majority of patients at a comprehensive cancer center expressed satisfaction with telemedicine visits in proportions that remained consistent beyond the end of the pandemic. These findings challenge health care systems to integrate telemedicine into routine cancer care and to overcome remaining technical challenges and barriers to ease of use.

Indexed as

COVID-19NeoplasmsPatient SatisfactionSARS-CoV-2TelemedicineAdultAgedFemaleHumansMaleMiddle AgedPandemicsSurveys and QuestionnairesUnited States

Identifiers

PMID39546309
PMCPMC11568458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.